14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ABVE vs HLF: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas HLF carries 35.2/100 (SELL) at $15.93 (5.3x Forward P/E, 9.8% operating margin).
Composite vs. Pillar Nuance: While ABVE currently prints a higher short-term Unified Composite Score (39.8/100 SELL vs. HLF 35.2/100 SELL), HLF captures the overall institutional head-to-head verdict (8–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (9.8% vs. -23.2% operating margin) and revenue trajectory (+6.0% vs. -45.0% YoY).
Defensive Composite Rating Caution: Although HLF compares more favorably head-to-head, both ABVE (39.8/100 SELL) and HLF (35.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile HLF trades in a Markup technical trend (SURGE options phase, RSI 68.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABVE vs HLF. Trailing 12-month operating profitability (ABVE -23.2% vs HLF 9.8%) and valuation multiples (ABVE N/M vs HLF 5.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Packaged Foods value chain with $1.6B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment67.8% of Rev ($3.58B)
90D Engineering Disclosures0 Published
Investor FAQ ABVE vs HLF Key Questions & Quantitative Answers
As of Nov 16, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABVE carries a Unified Composite Score of 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin), whereas HLF carries 35.2/100 (SELL) at $15.93 (5.3x Forward P/E, 9.8% operating margin). Composite vs. Pillar Nuance: While ABVE currently prints a higher short-term Unified Composite Score (39.8/100 SELL vs. HLF 35.2/100 SELL), HLF captures the overall institutional head-to-head verdict (8–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (9.8% vs. -23.2% operating margin) and revenue trajectory (+6.0% vs. -45.0% YoY). Defensive Composite Rating Caution: Although HLF compares more favorably head-to-head, both ABVE (39.8/100 SELL) and HLF (35.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: ABVE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0); meanwhile HLF trades in a Markup technical trend (SURGE options phase, RSI 68.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
HLF leads the Growth & Scale pillar: ABVE posts -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin), compared with HLF at +6.0% YoY revenue growth and +31.5% YoY earnings growth on $5.28B TTM revenue (77.6% gross margin, 9.8% operating margin). On trailing 12-month operating scale, ABVE generates $295M in USD-normalized revenue versus $5.28B for HLF. In operating R&D and SG&A reinvestment, ABVE deploys 20.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus 67.8% of Rev ($3.58B) (0 disclosures) for HLF.
HLF screens cheaper on headline valuation multiples. ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin), whereas HLF trades at 5.3x Forward P/E, 8.9x Trailing P/E, 0.61x PEG, and 0.6x EV/Revenue (6.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABVE (0.0% ROE) versus HLF (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk). By comparison, HLF carries 77.8% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.21x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.08β · 48% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.